Monthly Archives: April 2022

What you need to know about natural, organic and vegan wines – Atlantic City Weekly

Posted: April 19, 2022 at 2:40 am

If you are seeking a naturally lower calorie wine, look for dry wines with a lower ABV, such as Prosecco (brut or extra dry), dry Riesling, or Gamay. These wines typically fall on a spectrum of 80 to 120 calories per glass.

Q: Karen S. from Margate asks, Whats the difference between a natural wine and an organic wine?

A: Hi Karen! Natural wines and organic wines have a lot in common. Most significantly they share a concern for the earth and sustainable practices, but there are also several key differences.

To be certified organic by the USDA, a wine must be made without genetic engineering, and it must undergo a rigorous process of inspections and assessments. The grapes must be grown organically without synthetic fertilizers, and all other ingredients such as yeast and fining agents must be certified organic, as well. While sulfites are commonly added to wines as an additional preserving agent or to enhance flavor, organic wines cannot have added sulfites. Wines labeled as made with organic grapes have slightly less restrictions, but it is still a feat for winemakers to achieve this certification.

Natural wine, on the other hand, is not a legal certification. Rather, its a loose term that refers to wines made with little to no intervention by the winemaker. This means grapes are grown without the assistance of pesticides, grapes are handpicked, and juice is fermented into wine using only native yeasts. These yeasts occur naturally on the fruit, and winemakers allow fermentation to start spontaneously, rather than controlling fermentation with the addition of cultured yeasts. While natural wines wont necessary be certified organic, one could argue that they exemplify the most ancient, non-invasive method of winemaking.

See the original post:
What you need to know about natural, organic and vegan wines - Atlantic City Weekly

Posted in Genetic Engineering | Comments Off on What you need to know about natural, organic and vegan wines – Atlantic City Weekly

Revising the lifecycle of an important human parasite | Penn Today – Penn Today

Posted: April 19, 2022 at 2:40 am

We have been interested in the romantic life of the parasite Cryptosporidium for some time, says Boris Striepen, a scientist in Penns School of Veterinary Medicine.

Cryptosporidium is a leading cause of diarrheal disease in young children around the world. The intestinal parasite contributes to childhood mortality and causes malnutrition and stunting. How a parasite like this one reproduces and completes its life cycle has significant impact on child health.

Its the product of parasite sex, that is infectious agent here, a spore, that is transmitted by contaminated water, Striepen says. So, if you break its ability to have sex, you would break the cycle of transmission and infection.

In a new paper in PLOS Biology, Striepen and colleagues in his lab tread new ground in understanding how Cryptosporidium reproduces inside a host. Using an advanced imaging technique allowed the scientists to observe the entire lifecycle in the laboratory. They found the parasite completes three cycles of asexual replication and then directly switches to male and female sexual forms. Their observations refute an intermediate stage that was introduced in the 1970s and align well with the original description of physician and parasitologist Edward Tyzzer who discovered this pathogen more than a century ago.

What we have shown contradicts what you see in most textbooks today, including the description at the Centers for Disease Control and Prevention website, Striepen says. Its really a super simple lifecycle that is completed in a single host in three days and only has three characters: asexual cells, male cells, and female cells.

Other parasites, such as the malaria parasite Plasmodium, a cousin of Cryptosporidium, have more complicated and lengthy paths to follow an overall similar life cycle. While Crypto completes its lifecycle in one host, most malaria parasites move between two: a mosquito, where the parasites sexual reproduction occurs, and a human, where its asexual replication occurs.

Cryptosporidium is a great model to study parasite development; you can see analogous steps to what happens with the malarial parasite, but its much simpler because it all happens over only three days in one host, and we can observe it in simple cell cultures, Striepen says.

In earlier work on Cryptosporidium, Striepen and colleagues had found that sexual reproduction appeared necessary for the parasite to move from one host to infect another but also to sustain itself in a host during chronic infection. Blocking developmental progression and parasite sex thus presents itself as a strategy to cure or prevent infection.

Cryptosporidium is a minuscule single-cell parasite that invades and reproduces within the cells of the intestine of its hosts. To get a closer look at what was happening, the researchers developed a live-cell microscopic imaging technique to track the progression of the parasite through multiple days in cell cultures. Using genetic engineering they added a fluorescent label to the nucleus of each parasite, allowing them to observe the replication of the parasite in real time and to distinguish its different lifecycle stages.

What they saw was the parasites count to three, says Striepen. Rather than responding to environmental cues, the parasites followed a rigid built-in plan. After infecting a culture, the parasite underwent three cycles of asexual reproduction. Each cycle took about 12 hours, during which the parasite established a home within the host cell and replicated itself resulting in eight new infectious parasites. Those were then released to infect surrounding host cells.

After these three waves of amplification, their fate changes abruptly, and they turn into either male or female gametes, or sex cells, in a process that also took about 12 hours. Tracking individual parasites and their offspring the researchers found no evidence for a specialized intermediate form assumed by many textbooks, demonstrating direct development.

Interestingly, the parasite appeared pre-committed to their future fate and carried that plan from one host cell into the next in a way not yet understood.

The researchers were intrigued to see that male and females arise from the infectious forms released from the same asexual parasites. One of the really interesting aspects of sexual identity here is that it is not inherited and hard-wired in the genome but much more fluid, Striepen says. Theres an asexual cell that divides itself into genetically identical clones, and then those clones somehow become male or female on the fly, resulting in dramatically different cell shape and behavior.

Future research will focus on the molecular mechanism of commitment to understand how this life cycle is programmed into the parasites biology. Understanding the life cycle of Cryptosporidium is critical in thinking about how to create a vaccine or therapy for the disease, Striepen says.

How cells make decisions and execute developmental plans is one of the most fundamental questions in biology. Cryptosporidium offers a tractable system to better understand this mechanism in parasites. Hopefully we can gain insights that contribute to the understanding of cryptosporidiosis and malaria and lead the way to new urgently needed interventions for these important diseases.

Boris Striepen is the Mark Whittier and Lila Griswold Allam Professor of Microbiology and Immunology at the University of Pennsylvania School of Veterinary Medicine.

Striepens coauthors were lab members Elizabeth D. English, Amandine Gurin, and Jayesh Tandel.

The study was supported by grants from the National Institutes of Health to Striepen and a postdoctoral fellowship from the European Molecular Biology Organisation to Gurin.

Original post:
Revising the lifecycle of an important human parasite | Penn Today - Penn Today

Posted in Genetic Engineering | Comments Off on Revising the lifecycle of an important human parasite | Penn Today – Penn Today

22nd Century Group (Nasdaq: XXII) to Announce First Quarter 2022 Results on May 5, 2022 – Yahoo Finance

Posted: April 19, 2022 at 2:40 am

22nd Century Group, Inc

BUFFALO, N.Y., April 14, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving health and wellness through modern plant science, will host a live webcast on Thursday, May 5, 2022, at 10:00 AM ET to discuss its 2022 first quarter results. 22nd Century will report the Companys first quarter 2022 results in a press release at 6:00 AM ET the same day.

During the webcast, James A. Mish, chief executive officer; Michael Zercher, chief operating officer; and Richard Fitzgerald, chief financial officer, will review financial results and discuss progress made in each of the Companys three franchises.

Following prepared remarks by management and slide presentation, the Company will host a Q&A session, during which management will accept questions from interested analysts. Investors, shareholders, and members of the media will also have the opportunity to pose questions to management by submitting questions through the interactive webcast during the event.

The live and archived webcast, interactive Q&A and slide presentation will be accessible on the Events web page in the Company's Investor Relations section of the website, at http://www.xxiicentury.com/investors/events. Please access the website at least 15 minutes prior to the start of the webcast to register and, if necessary, download and install any required software.

About 22nd Century Group, Inc.22nd Century Group, Inc. (Nasdaq: XXII) is a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science. With dozens of patents allowing it to control nicotine biosynthesis in the tobacco plant, the Company has developed proprietary reduced nicotine content (RNC) tobacco plants and cigarettes, which have become the cornerstone of the FDAs Comprehensive Plan to address the widespread death and disease caused by smoking. The Company received the first and only FDA MRTP authorization of a combustible cigarette in December 2021. In tobacco, hemp/cannabis, and hop plants, 22nd Century uses modern plant breeding technologies, including genetic engineering, gene-editing, and molecular breeding to deliver solutions for the life science and consumer products industries by creating new, proprietary plants with optimized alkaloid and flavonoid profiles as well as improved yields and valuable agronomic traits.

Story continues

Learn more at xxiicentury.com, on Twitter, on LinkedIn, and on YouTube.

Cautionary Note Regarding Forward-Looking StatementsExcept for historical information, all of the statements, expectations, and assumptions contained in this press release are forward-looking statements. Forward-looking statements typically contain terms such as anticipate, believe, consider, continue, could, estimate, expect, explore, foresee, goal, guidance, intend, likely, may, plan, potential, predict, preliminary, probable, project, promising, seek, should, will, would, and similar expressions. Actual results might differ materially from those explicit or implicit in forward-looking statements. Important factors that could cause actual results to differ materially are set forth in Risk Factors in the Companys Annual Report on Form 10-K filed on March 11, 2021. All information provided in this release is as of the date hereof, and the Company assumes no obligation to and does not intend to update these forward-looking statements, except as required by law.

Investor Relations & Media Contact:Mei Kuo22nd Century Group, Inc.Director, Communications & Investor RelationsT: 716-300-1221mkuo@xxiicentury.com

Darrow Associates Investor RelationsMatt KrepsT: 214-597-8200mkreps@darrowir.com

Read more here:
22nd Century Group (Nasdaq: XXII) to Announce First Quarter 2022 Results on May 5, 2022 - Yahoo Finance

Posted in Genetic Engineering | Comments Off on 22nd Century Group (Nasdaq: XXII) to Announce First Quarter 2022 Results on May 5, 2022 – Yahoo Finance

Synthetic Biology Market Present Scenario on Growth Analysis Along with Key Industry Players – Taiwan News

Posted: April 19, 2022 at 2:40 am

Synthetic biology is a novel area of research that is the amalgamation of multiple disciplines such as molecular biology, biotechnology, biophysics and genetic engineering among others. There are chiefly two approaches used in synthetic biology namely, top down approach and bottom up approach. Top-down approach involves the re-design and fabrication of existing biological systems for producing synthetic products. Bottom-up approach involves designing and construction of de novo biological systems or devices that do not exist in nature. An impending need to understand the functioning of genetic elements, cells and biological processes has led to the emergence of synthetic biology. Synthetic biology products are used across many industries, including pharmaceutical & diagnostics, energy, bioplastics and environment.

World synthetic biology market was valued at $ 5,245.7 million in 2015, growing at a CAGR of 23% during the forecast period. Assistance from government and private organizations, rising number of synthetic biology research entities and declining cost of DNA sequencing & synthesizing are the major factors driving the market growth.

Request To Download Sample of This Strategic Report:-https://reportocean.com/industry-verticals/sample-request?report_id=26889

Market Statistics:

The file offers market sizing and forecast throughout 5 primary currencies USD, EUR GBP, JPY, and AUD. It helps corporation leaders make higher choices when foreign money change records are available with ease. In this report, the years 2020 and 2021 are regarded as historic years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2030 are viewed as the forecast period.

The Centers for Medicare and Medicaid Services report that US healthcare expenditures grew by 4.6% to US$ 3.8 trillion in 2019, or US$ 11,582 per person, and accounted for 17.7% of GDP. Also, the federal government accounted for 29.0% of the total health expenditures, followed by households (28.4%). State and local governments accounted for 16.1% of total health care expenditures, while other private revenues accounted for 7.5%.

This study aims to define market sizes and forecast the values for different segments and countries in the coming eight years. The study aims to include qualitative and quantitative perspectives about the industry within the regions and countries covered in the report. The report also outlines the significant factors, such as driving factors and challenges, that will determine the markets future growth.

On the contrary, bio-safety & bio-security issues, would hinder the market growth. The issues related to the misuse of synthetic biology or possibilities of accidental release of pathogens into free atmosphere would remain as a key challenge worldwide. However, rising demand for bio-fuels, growing awareness in emerging economies and rising R&D investments for synthetic drugs and vaccines would offer lucrative opportunities in the market.

Based on geography, the market is segmented across North America, Europe, Asia-Pacific and LAMEA regions. In 2015, Europe was the leading geography in terms of revenue generation followed by North America. Further, Europe would continue to maintain its lead position through 2020 owing to constant support from European government and private organizations, establishment of small start-ups and investment by leading companies especially in the biofuel segment. Asia Pacific is projected as the fastest growing market owing to increasing number of research entities.The report provides a comprehensive analysis of the leading companies operating in the world synthetic biology market.

Get a Request Sample Report:https://reportocean.com/industry-verticals/sample-request?report_id=26889

Key companies profiled in the report are Thermo Fischer Scientific, GenScript, DNA2.0, Integrated DNA technologies, Eurofins Scientific, Inc., Origene technologies, Scientific genomics Inc. Editas Medicine, Inc., Pareto Biotechnologies, Blue heron, TeselaGen, Twist biosciences, Syntrox Inc., and others.

Key Benefits

This report provides an extensive analysis of the current and emerging market trends and dynamics in the world synthetic biology market.The report provides a detailed analysis of the current market and estimations during 20142020, which would enable the stakeholders to capitalize on the prevailing market opportunities.The synthetic biology market scenario has been comprehensively analyzed in accordance to key geographical regions.The key market players operating in the market have been profiled in the report, and their strategies have been thoroughly analyzed to understand the competitive outlook of the market.Competitive intelligence highlights the business practices followed by leading market players across geographies.SWOT analysis enables to study the internal environment of the leading companies for strategy formulation

KEY MARKET SEGMENTS:

The world Synthetic Biology market is segmented as:

By Products

Synthetic DNASynthetic oligosSynthetic genesSoftware toolsChassis organismsSynthetic clonesSynthetic cells

Request full Report-https://reportocean.com/industry-verticals/sample-request?report_id=26889

By Technology

Nucleotide synthesis and sequencingBioinformaticsMicrofluidicsGenetic engineering

By Application

Pharmaceuticals and diagnosticsChemicalsBiofuelsBioplasticsOthers (Environment, agriculture & aquaculture)

By Geography

North AmericaEuropeAsia PacificLAMEA

Table of Content:

Key Questions Answered in the Market Report

How did the COVID-19 pandemic impact the adoption of by various pharmaceutical and life sciences companies? What is the outlook for the impact market during the forecast period 2021-2030? What are the key trends influencing the impact market? How will they influence the market in short-, mid-, and long-term duration? What is the end user perception toward? How is the patent landscape for pharmaceutical quality? Which country/cluster witnessed the highest patent filing from January 2014-June 2021? What are the key factors impacting the impact market? What will be their impact in short-, mid-, and long-term duration? What are the key opportunities areas in the impact market? What is their potential in short-, mid-, and long-term duration? What are the key strategies adopted by companies in the impact market? What are the key application areas of the impact market? Which application is expected to hold the highest growth potential during the forecast period 2021-2030? What is the preferred deployment model for the impact? What is the growth potential of various deployment models present in the market? Who are the key end users of pharmaceutical quality? What is their respective share in the impact market? Which regional market is expected to hold the highest growth potential in the impact market during the forecast period 2021-2030? Which are the key players in the impact market?

Inquire or Share Your Questions If Any Before the Purchasing This Report

https://reportocean.com/industry-verticals/sample-request?report_id=26889

About Report Ocean:We are the best market research reports provider in the industry. Report Ocean believes in providing quality reports to clients to meet the top line and bottom line goals which will boost your market share in todays competitive environment. Report Ocean is a one-stop solution for individuals, organizations, and industries that are looking for innovative market research reports.

Get in Touch with Us:Report Ocean:Email: sales@reportocean.comAddress: 500 N Michigan Ave, Suite 600, Chicago, Illinois 60611 UNITED STATESTel: +1 888 212 3539 (US TOLL FREE)Website:https://www.reportocean.com

Read the original post:
Synthetic Biology Market Present Scenario on Growth Analysis Along with Key Industry Players - Taiwan News

Posted in Genetic Engineering | Comments Off on Synthetic Biology Market Present Scenario on Growth Analysis Along with Key Industry Players – Taiwan News

12 Reader Views on Where America Is Going Wrong – The Atlantic

Posted: April 19, 2022 at 2:40 am

This is an edition of Up for Debate, a newsletter by Conor Friedersdorf. On Wednesdays, he rounds up timely conversations and solicits reader responses to one thought-provoking question. Soon after, he publishes some thoughtful replies. Sign up for the newsletter here.

Last week I asked readers, What worries you most about the direction of the country? For Adam, the answer is rooted in a perception that were underestimating what is at stake when we act:

The thing I worry about the most is breaking unfixable things. I think the modern era, especially defined by the GOP (but also by the far left), is more about performance than production. Our leaders dont seem to care about fixing problems, or even proposing solutions, just popularity contests, scoring points, and seeing how far they can push the envelope to stay in power. This didnt used to worry me as much. While Congress was always a procrastinator, they tended to get their homework done on time.

But I fear in the next few years, something will break that cant be fixed. Republicans are telling us theyre going to try to steal the next election. Democrats seem to be jamming their heads in the sand to avoid the issue and hope that two centuries of rule-following will save us. It wont. The more America breaks, the more other nations will step in to fill the void. What if the dollar ceases to be the world reserve currency? Most Americans cant comprehend the benefits we gain from this status, or the economic and lifestyle pain well suffer if it goes away. Once its gone, its gone. Theres no going back. What if a debt ceiling fight takes us over the edge? That might be all it takes. And can anyone tell me with a straight face they trust the leaders in Congress as responsible stewards of the country to NOT take us over that cliff? Damn the consequences?

Congress has gotten used to passes and do-overs. But there are things that will break us, will fundamentally alter life as we know it, well below the apocalyptic threats of climate change or nuclear war, but a new era of real, actual, American decline (not the made up American decline BS used in election ads). And were so polarized, so used to choosing and accepting less than we deserve in our leaders, I fear well lower the bar and accept it.

B. laments the abandonment of rationalism:

As a healthcare provider recommending COVID vaccination to skeptical patients, we are now educated by the CDC and our medical organizations that the best way to do this is, dont try to convince them using facts. In a nutshell this is an example of what worries me the most. The abandonment of any effort to make difficult decisions using rationalism.

So instead of approaching these decisions by using as much science, math, and reason as we have availableand acknowledging that almost all difficult decisions need to be made using incomplete informationweve now moved to a faith-based system. We choose a source of information like a cable news network or a minister or a politician or an internet community. And then just believe whatever they say rather than trusting institutions, fact-checking, and content experts. When both sides do that, there is no room for either compromise or getting anyone to agree that they might be wrong (now or in the past). We are thus left with no ability to address complicated, difficult issues like climate change, budget deficits, entitlement programs, or healthcare reform.

Jill is thinking about income inequality:

I am particularly interested right now in the debate spawned by Matthew Stewarts The Birth of a New American Aristocracy, the 9.9%, who own more wealth than all other Americans put together, and are perpetuating wealth inequality like never before. I am surprised to find myself in this class, and pondering how to get more clarity about the nature of the problem that our emergence as a class represents, and what can be done about this.

Matt worries that we dont invest more in the quality of education for all:

If we want to stay a leading force in the world, we should prioritize having the best educated population. Right now it seems like we are being forced into an absurd debate over preventing kids from being groomed or indoctrinated. Its an argument against activity thats not occurring, doing damage to the teaching field, school boards, and the overall effectiveness of education. We could be spending time and resources to give young generations the best education available, but we arent. Its going to haunt our country and inhibit our ability to progress as a competitive economy.

What makes me optimistic is to see the independent thought of the younger Gen Z population. They seem to understand social media and information in a different way that I hope allows them to identify mis/disinformation more naturally than older generations. They have skills and talents which will allow them to be successful in new ways. Millennials are uniquely well educated as a generation and will offer a lot of value as leaders. I look forward to a world more generally controlled by Millennials and Gen Z.

Tony believes that were doomed by the attack on truth that he perceives:

When I was a student in the late 90s and early aughts at Evangelical colleges, we were terrified of postmodernism. Perhaps ironically, we now find ourselves in a cultural moment foretold by those Evangelicals, but for different reasons and with many of them on the other side of truth. The fact that charlatans and pathological liars are allowed unfettered access to airwaves and social media is disastrous. It works for an anarchic state perhaps but not for a functioning republic. What we are seeing now is the nightmare underbelly of democracy that the Founders tried to prevent by implementing certain checks and balances. I see no evidence that this experiment is leading in a direction other than failure.

L. has concerns about excessive questioning of everything, but finds hope at work:

Im a middle school educator, teaching social studies in the Bronx. What troubles me is the denigration of institutions. I dont just mean government. We as a society have questioned and doubted so much (on both the left AND the right) that the familiar groundings of societyfamily, education, commercebecome objects of constant suspicion.

Social media is a huge culprit in this: any medium that makes a fool an instant expert is a conduit for anarchy. However, I found hope in my classroom. We were discussing the difficult legacy of the Declaration of Independence. 41 slave owners were among the 56 signers of a document that stated all men are created equal. I asked if the flaws of these men invalidated the ideas in the document (an idea that gets wide circulation in critical studies). One by one, my students disagreed. They all said basically the same thing: the ideas are too important to throw away. They are ideas worth fighting for, ideas that should be what we as Americans should work towards every day. I almost cried.

Sophia fears an environment that is increasingly efficient, polluted, ugly, controlled, tamed, tracked; a culture in which children and adults are increasingly afraid, lonely, and anxious despite objective safety; and a culture in which people die after years of slow deterioration of mind and body, while she finds hope in genetic engineering; an explosion of beautiful art in the form of writing, television, movies, and fashion; an end to farm animal exploitation through the invention of lab grown meat; and assisted suicide legislation and more good death culture.

Read: 14 reader views on sexuality and gender in the classroom

Like other readers, Isaac worries about social medias effect on society:

Social media as it exists today degrades human experience. I am fairly young but I dont use it. I believe the epidemics of anxiety, loneliness, and depression that are wrecking my generation are due in large part to the commercialization of social interaction. These platforms exploit human weakness and our tendency to believe things that we agree with, intensify in-group out-group thinking, and turn truth into a political football.

What worries me is that these platforms will remain central to all forms of public discourse, and that Americans will find it impossible to act as one people. We face numerous existential challenges. We cannot surmount them without a shared set of facts and values. I think that it is possible to create beneficial social mediathere are values to connectionbut that is not what we have today and unless there is a recognition that these businesses are sucking our attention dry at the expense of the things that matter most (love, compassion, truth, reason) we are going to be unable to surmount our challenges and I think we will be in an increasingly isolated, atomized, and alienating culture.

What gives me hope is this: America is a strong country. We have spent the last decade at least with no clear enemy, no clear purpose, and a pervasive need to self doubt and eat our own. If we play to our strengths, recognize the incredible gift of our democracy, our geography, and our people, then we could accomplish almost anything.

Errol fears that we are too pessimistic:

I worry that were entering a world of overcorrection.

I love this country, where you can break free of the worst and incorporate the best of the culture youve come from. That is one of the best ideas a society has ever had. But now mixing cultures is cultural appropriation and a bad thing. Weve allowed the most immigrants ever in the history of any government, yet weve somehow become the border wall country. Im not saying we are without serious problems, but we do do good and have a rich positive history as well. We invented airplanes and movies. We landed on the moon! These are pretty remarkable progressive steps for the species. The world is worse without the US in it, and while we can and should do better, it would be nice to acknowledge the good once in a while and to take a break from the constant negativity.

Martin worries about the degradation of local control:

My concern is that so many individuals, especially those in the current political class, are forgetting that we are a Federal Republic with a principles-based constitution underpinned by a liberal (in the classic, not political, sense) set of values. I guess you can ask, why does this matter?

In a Federal Republic a significant portion of decision-making can be pushed to local communities. What is unfortunate is that each time there is conflict between various layers of government our politicians in one party or the other seem to want to aggregate power farther from the citizenry. Over the past 20 years we have watched both California and Texas push for nationalization of their legislative priorities followed by the cry for states rights as soon the Federal government changed hands. And in both cases we have watched as these states have mandated behavior at the county, city and even school board level in conflict with local desires. As long as the principles enshrined in the 14th amendment ( nor deny to any person within its jurisdiction the equal protection of the laws) are met, federalism allows for a multitude of laboratories in which to innovate and learn. Just as none of us really think technological innovation should occur only in one location, we should not believe that of political innovation.

Michael is so worried that he has thought about where else he might move:

I am frankly terrified about the direction of the country. I have never felt this pessimistic about where we are heading. It appears we are in an endlessly polarized environment where there is no unity and little or no concern for anyone who is not in our tribe. As someone who has been a liberal democrat all my life, and has mostly, but not always, lived in the northeast US, I appreciate that to some extent I live in a bubble surrounded by like-minded people. But many of us pay attention to current events and my concern is shared by many. I just had lunch with a close friend yesterday, and we were talking about what other countries might be a more hospitable, less stressful place to live. I have had more than a few sleepless nights thinking about this.

What am I optimistic about? One thing that I find both reassuring and perhaps a source of optimism is that my three adult children seem far less troubled than I am. They are busy with careers, relationships, house hunting, etc. Maybe as someone who is semi-retired, I just have too much time to think about things. It is almost as if the best case scenario is that as the federal government becomes less empowered (due to the originalism of the Supreme Court), states will evolve separately and perhaps people will gravitate to states that are more welcoming to them. We would no longer be a united country (I think that train has left the station anyway), we would be in more of a cold civil war. The enormous downside of that, of course, would be a fractured response to International events. It appears we are headed toward a more conflictual world stage and having a fractured and ineffectual US would certainly not help.

For Eric, theres nothing to be pessimistic about but pessimism itself:

I actually dont worry that much about the direction of the country, but I do worry about issues with the country. The thing that worries me most is the popularization of the end-of-the-world framework, often seen in a religious context, being applied to American democracy. This concerns me, because, right now, this type of pessimism is broadly and simultaneously permeating both the left and the right. I cant think of a precedent for this. There are always fatalistic pockets of society, but American fatalism appears to have gone mainstream. Democracy is just an idea. It exists solely in our collective imagination. If enough of us stop believing its a good idea, then it wont withstand an organized assault.

This is a serious problem. But, as I said, Im not that worried. Weve been through divisive times before. We survived an actual bloody Civil War over the right to own humans, so weve fought it out over the most serious issue. I think its a strong precedent for success. And were seeing tons of participation in the allegedly rigged process, from both sides.

Were living through the first time in human history when we all hear the thoughts of anybody who wants to speak their thoughts out loud. And a lot of people (but not all) seem to want to speak. But sometimes we forget that talk is cheap. People say all kinds of things that they dont mean, especially from behind a keyboard, especially if theyre anonymous. There are people who say abhorrent things that they actually believe. But there are a lot of people who speak incredibly flippantly about all sorts of stuff who, when push-comes-to-shove, would be forced to admit they dont mean it. Just think of the tough guy talk some people use behind their keyboards, who are actually sad, pathetic wimps.

The freedom to say things inconsequentially via social media has dovetailed with the desire for attention and a perverse incentive structure that rewards extreme speech, so a lot of people appear disenchanted with American democracy, but theyre living their best lives thanks to it. Now, it may be the case that the insincere language reaches such a fever pitch that coming generations internalize it without realizing how performative it is, and then we could be screwed. But I think humans will adapt to a world with social media and will find solutions to the malaligned incentive structure. People will continue realizing that American democracy, for all its flaws, is still pretty awesome, and well keep improving it.

Thanks for your contributions. I read every one that you send. See you Wednesday.

More here:
12 Reader Views on Where America Is Going Wrong - The Atlantic

Posted in Genetic Engineering | Comments Off on 12 Reader Views on Where America Is Going Wrong – The Atlantic

Nasal Spray Research to Combat COVID-19 and Other Respiratory Infections Awarded Grant – Genetic Engineering & Biotechnology News

Posted: April 19, 2022 at 2:40 am

Jonathan Dordick, PhD, from Rensselaer Polytechnic Institute, and other collaborators from Rensselaer and Albany Medical College have been awarded $500,000 from the New York State Biodefense Commercialization Fund to engage in research for the development of a Pentosan Polysulfate (PPS)-based nasal spray to block COVID-19.

Despite advances in both therapeutics and vaccines for COVID-19, there remains a critical need to develop a simple, easy to use, and highly effective prophylactic to prevent transmission and serious illness as a result of infection with SARS-CoV-2, saidDordick, institute professor of chemical/biological engineering at Rensselaer, and co-director of the Heparin Applied Research Center (HARC). Since the virus uses the nasal passages as a first line of infection, an ideal approach is to use a safe and effective nasal spray. We have shown that pentosan polysulfate (PPS), an FDA-approved drug for an entirely different indication, shows strong binding to SARS-CoV-2, thereby neutralizing the virus.

Our goal now is to incorporate PPS into a nasal spray formulation to block SARS-CoV-2 infection either pre- or post-exposure. Moreover, a similar mechanism of infection is used by a number of viruses, including other coronaviruses and some common cold viruses, and thus the PPS-based nasal spray could be useful against other respiratory infections.

Dordick is the principal investigator (PI) of the project and will lead the research. He has expertise in human cell culture and high-throughput screening, SARS-CoV-2 pseudovirus preparation and screening, drug discovery, and toxicology. He has founded four companies, including three in drug discovery, and he will be responsible for project oversight.

Despite the success of vaccines to prevent COVID-19 infection and reduce severity of breakthrough infections, there remains a notable resistance to vaccination, and waning immunity offered by vaccines against emerging variants may necessitate new generations of vaccines. There has been success in advancing therapeutics, such as dexamethasone, remdesivir, molnupiravir, paxlovid, and monoclonal antibodies.

None of the vaccines and therapeutics provide for a combined prophylactic/early-stage therapeutic that can be administered at home and is broadly applicable to other respiratory infections. Therefore, new agents are urgently needed for prophylaxis/early-stage treatment of COVID-19.

Home or physicians office use is expected to have a high degree of public acceptance and will help to address outbreaks of COVID-19, particularly as new variants emerge, and we enter the endemic phase of the disease. A prophylactic nasal spray to prevent COVID-19 infection could be used pre- or post-exposure and could be used daily by persons who are unable to be vaccinated due to medical reasons.

Individuals in healthcare, transportation, and food services are particularly vulnerable to SARS-CoV-2 and would benefit from use of a prophylactic nasal spray.

Researchers say they expect the PPS nasal spray to be useful against future infectious disease threats and that the impact of the spray is likely to extend well beyond the current COVID-19 pandemic.

See original here:
Nasal Spray Research to Combat COVID-19 and Other Respiratory Infections Awarded Grant - Genetic Engineering & Biotechnology News

Posted in Genetic Engineering | Comments Off on Nasal Spray Research to Combat COVID-19 and Other Respiratory Infections Awarded Grant – Genetic Engineering & Biotechnology News

Jayhawks shine at 2022 Capitol Graduate Research Summit | The University of Kansas – KU Today

Posted: April 19, 2022 at 2:38 am

LAWRENCE Three University of Kansas students received honors during the 19th annual Capitol Graduate Research Summit in Topeka at the end of March. Rohit Singh, Jacob Hodge and Lauren Johnson were each recognized for their outstanding research and presentations at an event that brings together the top graduate student researchers in the state of Kansas.

Rohit Singh, doctoral student in mechanical engineering, received a research award from the Office of Graduate Studies at the Lawrence campus for the project A Novel Technology to Treat Blood-Vessel Related Disease through Space and Time Synchronized Ultrasound and Laser.

A non-visible micron-sized bubble created by ultrasound plus laser inside a blood vessel can treat diseases related to blood vessels, Singh said. It can dissolve blood clots inside vessels in case of deep vein thrombosis disease, and it can close leaky microvessels in the eye to prevent blindness caused by diabetic retinopathy and age-related macular degeneration.

This treatment method aims to improve the human condition and provide a useful alternative to existing treatment techniques that cost anywhere from $15,000 to $20,000 for deep vein thrombosis.

Rohits work explores innovative, non-invasive methods for treating vascular disease, said Jennifer Roberts, vice provost for graduate studies and academic affairs. The procedures he studies would provide preventative treatment for patients with potential blindness due to macular degeneration and diabetic retinopathy.

Jacob Hodge, doctoral student in bioengineering in the M.D.-Ph.D. Medical Scientist Training Program, received a research award from the Office of Graduate Studies at the Lawrence campus for the project Tailoring Stem Cell Therapies to Enhance Regenerative Wound Healing.

My research focuses on using a novel 3D printed biosystem to improve the regenerative capabilities of adult stem cells, Hodge said. Within our bodies, stem cells produce a vast number of compounds that aid in tissue regenerative processes. By utilizing our 3D printed tissue mimetic system, we can control the activity of stem cells and isolate these regenerative compounds to develop personalized medical therapies for a variety of soft tissue ailments, such as wound care.

Hodges research could lead to the development of novel tailorable therapeutics that lessen the economic burden of chronic wounds of patients in the Kansas health care system.

Jacob presented impactful research investigating new techniques for promoting healing for individuals with chronic wounds, Roberts said. Both he and Rohits research showcase the high-quality research underway at KU, and their results show real promise for directly impacting and improving the lives of Kansans.

Lauren Johnson, medical student in the School of Medicine, received a research award from BioKansas and the Office of Graduate Studies at the KU Medical Center for the project Should Breast Cancer Patients Have Preoperative Biopsy of Borderline Abnormal Axillary Lymph Nodes?

Johnsons research has implications for the future treatment of breast cancer patients in Kansas by making treatment more affordable.

The goal of my research project was to determine if a preoperative biopsy of borderline lymph nodes is helpful in the management of breast cancer patients, Johnson said. We found that biopsy is more often an unnecessary procedure as it was only helpful in 32% of patients. We hope this finding can limit travel time, financial burden and unnecessary procedures for breast cancer patients in Kansas.

The free Capitol Graduate Research Summit provides an opportunity for the public as well as Deputy Secretary of Business Development Paul Hughes and state senators and representatives to learn more about the important work of graduate students across the state.

Founded by graduate students 19 years ago, the summit brings attention to the innovative research conducted by students at state universities and emphasizes the public benefits of graduate students research. KU students joined graduate students from Emporia State University, Fort Hays State University, Kansas State University, Pittsburg State University and Wichita State University at the summit.

Top photo:From left to right, Kyung M. Min, Julia Russell, Max S. Fairlamb, Lauren Johnson, Amy Herman, Samantha Cintron, Elizabeth Thoenen, Siddharth Subham, Rohit Singh, Jacob Hodge and Micah Unruh pose after the Capitol Graduate Research Summit. Credit: Genevieve Prescher.Right photo: Jacob Hodge presents his project to Jennifer Roberts, vice provost for Academic Affairs and Graduate Studies.Credit: Genevieve Prescher.

Here is the original post:
Jayhawks shine at 2022 Capitol Graduate Research Summit | The University of Kansas - KU Today

Posted in Kansas Stem Cells | Comments Off on Jayhawks shine at 2022 Capitol Graduate Research Summit | The University of Kansas – KU Today

BioCardia Announces FDA Approval of Its IND for NK1R+ Mesenchymal Stem Cells for the Treatment of Patients Recovering from Acute Respiratory Distress…

Posted: April 19, 2022 at 2:35 am

SUNNYVALE, Calif., April 12, 2022 (GLOBE NEWSWIRE) -- BioCardia, Inc.[Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's Investigational New Drug (IND) application for BCDA-04, a proprietary allogeneic mesenchymal cell (MSC) population that is Neurokinin-1 receptor positive (NK1R+). This allows BioCardia to initiate its First-in-Human Phase I/II trial in adult patients recovering from Acute Respiratory Distress Syndrome (ARDS) due to COVID-19, with trial initiation expected in the third quarter of 2022.

The first part of the clinical trial will evaluate increasing doses of the NK1R+ MSCs and the optimal dose will be taken to Phase II in a randomized study in adult patients recovering from ARDS due to COVID-19. "This investigational cell therapy is administered intravenously (IV) and follows a significant body of compelling clinical results by NIH investigators and peer companies," said Ian McNiece, Ph.D., BioCardias Chief Scientific Officer. "After IV delivery, the cells migrate to the lungs for local therapeutic benefit. We expect the anti-inflammatory nature of these mesenchymal stem cells to have a positive impact in ARDS because of the interaction of the Neurokinin-1 receptors with Substance P, a neuropeptide that has long been known to be a primary mediator of inflammation in the lungs. Our goal is to help recovering patients with ARDS due to COVID-19 recover faster and more fully, while avoiding longer term respiratory issues."

"In addition to our critically important autologous cell therapies being studied for ischemic heart failure and chronic myocardial ischemia with refractory angina, the FDA's acceptance of this IND for patients recovering from ARDS is an important milestone in the development of our allogeneic mesenchymal stem cell therapy platform and validation for its potential to provide therapeutic benefit beyond the cardiovascular system," said Peter Altman, Ph.D., Chief Executive Officer. "Our off the shelf MSC platform may have significant advantages over others in clinical development for multiple indications because the MSCs express the biologically important NK1 receptor which binds Substance P. Our in-house clinical cell manufacturing is also expected to be an important strategic asset that enables rapid and cost-effective development."

About ARDS

Acute respiratory distress syndrome (ARDS) occurs when fluid builds up in the tiny, elastic air sacs (alveoli) in the lungs. The fluid keeps the lungs from filling with enough air, which means less oxygen reaches the bloodstream. This deprives organs of the oxygen they need to function. ARDS typically occurs in people who are already critically ill or who have significant injuries. Severe shortness of breath the main symptom of ARDS usually develops within a few hours to a few days after the precipitating injury or infection. Many people who develop ARDS don't survive. The risk of death increases with age and severity of illness. Of the people who do survive ARDS, some recover completely while others experience lasting damage to their lungs1. Based on preliminary clinical reports on COVID-19, respiratory failure complicated by ARDs is the leading cause of death for COVID-19 patients.2 Despite multiple clinical studies, no pharmacological treatments have proven effective for ARDS.3, 4

About BioCardia

BioCardia, Inc., headquartered in Sunnyvale, California, is developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary disease. CardiAMP autologous and NK1R+ allogeneic cell therapies are the Companys biotherapeutic platforms that enable four product candidates in clinical development. The CardiAMP Cell Therapy Heart Failure Trial investigational product has been granted Breakthrough designation by the FDA, has CMS reimbursement, and is supported financially by the Maryland Stem Cell Research Fund. The CardiAMP Chronic Myocardial Ischemia Trial also has CMS reimbursement. For more information visit:www.BioCardia.com.

FORWARD LOOKING STATEMENTS

This press release contains forward-looking statements that are subject to many risks and uncertainties. Forward-looking statements include, among other things, initiation of our BCDA-04 clinical trial, and the mechanism of action and ease of administration of our NK1R+ MSC therapy.

We may use terms such as believes, estimates, anticipates, expects, plans, intends, may, could, might, will, should, approximately or other words that convey the uncertainty of future events or outcomes to identify these forward-looking statements. Although we believe that we have a reasonable basis for each forward-looking statement contained herein, we caution you that forward-looking statements are not guarantees of future performance and that our actual results may differ materially from the forward-looking statements contained in this press release. As a result of these factors, we cannot assure you that the forward-looking statements in this press release will prove to be accurate. Additional factors that could materially affect actual results can be found in BioCardias Form 10-K filed with the Securities and Exchange Commission on March 29, 2022, under the caption titled Risk Factors. BioCardia expressly disclaims any intent or obligation to update these forward-looking statements, except as required by law.

_________________________________________________________________________________________________________

Media Contact:Anne Laluc, MarketingEmail:alaluc@BioCardia.comPhone: 650-226-0120

Investor Contact:David McClung, Chief Financial OfficerEmail:dmcclung@BioCardia.comPhone: 650-226-0120

(1)MayoClinic.Org

(2)Rajagopal K, Keller SP, Akkanti B, et al. Advanced pulmonary and cardiac support of COVID-19 patients, emerging recommendations from ASAIOa living working document. Circ Heart Fail. 2020 May;13(5).

(3)Thompson BT, Chambers RC, Liu KD (2017) Acute respiratory distress syndrome. N Engl J Med 377(19):19041905.

(4)3. Group RC, Horby P, Lim WS et al (2020) Dexamethasone in hospitalized patients with Covid-19preliminary report. N Engl J Med.

More here:
BioCardia Announces FDA Approval of Its IND for NK1R+ Mesenchymal Stem Cells for the Treatment of Patients Recovering from Acute Respiratory Distress...

Posted in Maryland Stem Cells | Comments Off on BioCardia Announces FDA Approval of Its IND for NK1R+ Mesenchymal Stem Cells for the Treatment of Patients Recovering from Acute Respiratory Distress…

Top Ways To Rejuvenate Your Body And Improve Your Well-being – The Southern Maryland Chronicle

Posted: April 19, 2022 at 2:35 am

Are you feeling run down and exhausted? Do you find yourself struggling to get through the day without a nap? If so, you may need to rejuvenate your body. There are many ways to do this, and this blog post will discuss some of the best methods. It will also talk about how improving your overall well-being can help improve your energy levels and mood. So if youre ready to feel like your old self again, keep reading.

One of the best ways to rejuvenate your body is to consider different types of therapy. This could include things like massages, acupuncture, or even yoga. These therapies can help to relax your muscles and improve your circulation. They can also help to reduce stress levels, which can be a big contributor to fatigue. Massages, in particular, can be very beneficial for improving energy levels. Acupuncture is another great option for those looking to rejuvenate their bodies. This ancient therapy has been used for centuries to help improve overall health. It involves the insertion of thin needles into specific points on the body. This can help to improve circulation and reduce stress levels.

On the other hand, yoga can be a great way to improve flexibility, strength, and stamina. It can also help to clear your mind and reduce stress. You can also consider stem cell therapy, but make sure that you consult with a qualified professional first. This type of therapy can be very beneficial because it can help to repair and regenerate damaged cells. It can also help to improve your overall health and well-being. If youre not sure what type of therapy would be best for you, consider talking to your doctor or a health professional.

Another great way to rejuvenate your body is to eat a healthy diet. This means eating plenty of fruits, vegetables, and whole grains. It also means avoiding processed foods, sugary drinks, and excessive amounts of caffeine. Eating a healthy diet can improve your energy levels, mood, and overall health. It can also help to reduce stress levels and improve your sleep quality. If youre not sure where to start, there are plenty of resources available online and in books. You can also talk to a nutritionist or dietitian for more specific advice.

Exercising regularly is another great way to rejuvenate your body. This is because it can help to improve your circulation, increase your energy levels, and reduce stress. Some of the best exercises for this include walking, running and swimming. However, its important to find an exercise that you enjoy and can stick with. Otherwise, you may not see the benefits. If you need some motivation to get started, consider signing up for a class or hiring a personal trainer. This way, youll be more likely to stick with it.

One of the most important things you can do for your body is to get enough sleep. Most adults need around eight hours of sleep per night. However, many people only get six or seven hours. This can lead to fatigue and other health problems. If youre having trouble sleeping, there are a few things you can try. First, make sure that your bedroom is dark and quiet. This will allow you to relax and fall asleep more easily. Second, avoid using electronics in bed. Finally, establish a regular sleep schedule and stick to it as much as possible.

Finally, strive to make changes in your lifestyle. This means things like reducing stress, quitting smoking, and getting regular exercise. These changes can be difficult to make, but theyre worth it in the long run. Not only will you feel better, but youll also be more likely to stick with them. If you need help making these changes, consider talking to your doctor or a counselor. They will be able to guide you in the right direction. Just make sure that youre ready to commit before you get started.

There are many different ways to rejuvenate your body. However, these are some of the best methods. If youre feeling run down and exhausted, consider trying one or more of these methods. You may find that you have more energy and feel better overall. Improving your well-being can also help to improve your energy levels and mood. So if youre ready to feel like your old self again, start by making some changes to your lifestyle. Rest assured that these simple changes can make a big difference in how you feel.

Like Loading...

Related

Go here to read the rest:
Top Ways To Rejuvenate Your Body And Improve Your Well-being - The Southern Maryland Chronicle

Posted in Maryland Stem Cells | Comments Off on Top Ways To Rejuvenate Your Body And Improve Your Well-being – The Southern Maryland Chronicle

Chronic Diseases Is Expected To Have Positive Impact On Stem Cell Characterization Kits Market Demand Bloomingprairieonline – Bloomingprairieonline

Posted: April 19, 2022 at 2:31 am

Stem cell characterization kitst Market sizeis done based on a triangulation methodology that is primarily based on experimental modelling approaches such as patient-level data or disease epidemiology for any key indications , number of procedures and install base analysis for any equipment to obtain precise market estimations for the base year as well as in historic data analysis.

Bottom-up approach is always used to obtain Stem cell characterization kits insightful data for the specific country/regions. The country specific data is again analyzed to derive data at a global level.

Market Overview:-

Stem cells are biological cells that can be converted into specific type of cells as per the bodys requirement. Stem cells are of two types, i.e., adult stem cells and embryonic stem cells. Stem cells can be used to treat various diseases such as cancer, neurodegenerative disorder, cardiovascular disorder and tissue regeneration. Stem cell characterization is the initial step for stem cell research.

Stem cell characterization kit is required to understand the utility of the stem cells in downstream experiments and to confirm the pluripotency of the stem cell.The growth of the stem cell characterization kits market is expected to be being fuelled by government funding for stem cell research.

To Remain Ahead Of Your Competitors, Request for Brochure https://www.factmr.com/connectus/sample?flag=B&rep_id=2691

Fact.MR, a leading authority on market research brings original, in-depth, and insightful reports to investors On Stem Cell Characterization Kits Market Sales & Demand. Fact.MRs report will highlight various growth forecasts, key trends, and notable segments ripe for upcoming investments.

Key Parameters analyzed while estimating the Stem Cell Characterization Kits market include:

Overall Population by age group/Prevalence or Incidence of any disease/Treatment Seeking Rate/Dosage pattern/Average duration of treatment/Overall treatment cost and Reimbursement are considered.

Overall Population/Prevalence or Incidence of disease/treatment seeking rate/ average duration of the treatment/average number of devices used per patient / average number of procedure per device/ average selling price per device/reimbursement are considered.

Number of Healthcare facilities (Hospitals/Ambulatory Surgical Centers/Clinics etc.)

Average number of devices installed per facilities/ lifespan of the devices/replacement rate of the equipment/new sales of the equipment per year/average selling price per equipment are considered.

Extensive rounds of primary and a comprehensive secondary research have been leveraged by the analysts to arrive at various estimations and projections for Sales & Demand of Stem Cell Characterization Kits, its market share, production footprint, current launches, agreements, ongoing R&D projects, and market strategies.

SWOT analysis has been performed in the Sales study to investigate the strengths, weaknesses, opportunities and threats of each player, both at global and regional levels

Company share analysis is used to derive the size of the global Stem Cell Characterization Kits market. As well as a study of the revenues of companies for the last several years also provides the base for forecasting the market size and its Sales growth rate.

This study offers an overview of the existing market trends, metrics, drivers, and restrictions and also offers a point of view for important segments. The report also tracks product and services demand growth forecasts for the market.

Stem Cell Characterization Kits Market Segmentation:

Based on type of stem cell, the stem cell characterization kits market is segmented into:

Based on application, the stem cell characterization kits market is segmented into:

Based on end user, the stem cell characterization kits market is segmented into:

North America and Europe are expected to witness significant growth in the global stem cell characterization kit market over the forecast period. This is owing to presence of key manufacturers and researchers of stem cell based therapies in these regions. Moreover, manufacturers such as ThermoFisher Scientific, and Becton Dickinson providing stem cell assays are present in North America region.

Asia Pacific is expected to show significant growth in the stem cell characterization kit market over the forecast period, as researchers from China and Japan are working on stem cell based therapies. For instance, in 2017, clinical trials of embryonic stem cells were launched in China for Parkinsons disease.

The Stem Cell Characterization Kits Sales study analyzes crucial trends that are currently determining the growth of Stem Cell Characterization Kits Market.

There is also to the study approach a detailed segmental review. The report mentions growth parameters in the regional markets along with major players dominating the regional growth.

The Key trends Analysis of Stem Cell Characterization Kits also provides dynamics that are responsible for influencing thefuture Sales and Demand of Stem Cell Characterization Kits marketover the forecast period.

Request Customized Report as Per Your Requirementshttps://www.factmr.com/connectus/sample?flag=RC&rep_id=2691

The report covers following Stem Cell Characterization Kits Market insights and assessment that are helpful for all participants involved in the Stem Cell Characterization Kits market:

NOTE:Our team are studying Covid19 and its impact on the Sales growth of Stem Cell Characterization Kits market and where necessary we will consider the Covid-19 footmark for better analysis of the market Demand and industries outlook. Contact us cogently for more detailed information.

Further, the Stem Cell Characterization Kits market Survey report emphasizes the adoption pattern And Demand of Stem Cell Characterization Kits Market across various industries.

The Stem Cell Characterization Kits Sales study offers a comprehensive analysis on diverse features including production capacities, Stem Cell Characterization Kits demand, product developments, Stem Cell Characterization Kits revenue generation and Stem Cell Characterization Kits Market Outlook across the globe.

Competitive Landscape Analysis On Stem Cell Characterization KitsMarket:

In this report, leading market participants involved in the manufacturing of Stem Cell Characterization Kits are covered. Analysis regarding their product portfolio, key financials such as market shares and sales, SWOT analysis and key strategies are included in this report. To provide decision-makers with credible insights on their competitive landscape, the Stem Cell Characterization Kits industry research report includes detailed market competitive landscape analysis.

Some of the key participants in the global Stem Cell Characterization Kits Market include :

Examples of some of the key participants in the stem cell characterization kits market identified across the value chain include Merck KGaA, Celprogen, Inc., Creative Bioarray, Thermo Fisher Scientific Inc., BD Biosciences, R&D Systems, Inc., System Biosciences, Cosmo Bio USA, BioCat GmbH, and DS Pharma Biomedical Co., Ltd.

Enquiry Before Buying https://www.factmr.com/connectus/sample?flag=EB&rep_id=2691

After glancing through the report on globalStem Cell Characterization Kits market Demand, readers will get valuable insight into the following:

The Survey report highlights the growth factors and entry barriers for the key players and talks about the new trends emerging in the globalStem Cell Characterization Kitsmarket.

In addition to this, the study sheds light on changing market size, revenue growth, and share of important product segments. Analysts at Fact.MR give prominent data on recent technological developments and product developments in the Stem Cell Characterization Kits Demand during the assessment period.

A comprehensive estimate on Demand of Stem Cell Characterization Kits market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of Stem Cell Characterization Kits market during the forecast period. Price point comparison by region with global average price is also considered in the study.

Market Snapshot

The rising prevalence of cancer, cardiovascular disorders and neurodegenerative diseases and the role of stem cell therapy in treating these diseases is projected to drive the growth of stem cell characterization kit market.

As per the American Cancer Society, in 2017 cancer accounted around 1 out of 4 deaths in the U.S. and was the second most common cause of deaths in the U.S.

Stem cell therapy and stem cell transplant has huge potential to treat such chronic diseases, which is expected to have a positive impact on the growth of the stem cell characterization kits market.

Stem cell transplant is useful for the treatment of spinal cord injury, stroke, and Alzheimers disease, which is expected to fuel the adoption of stem cell characterization kits over the forecast period.

The Stem Cell Agency, California, is working on the development of new stem cell-based therapies for chronic diseases such as cancer and rare diseases, where stem cell characterization kits are primarily required.

Stem cell characterization kit is also required to identify the appropriate stem cells for the treatment of -Thalassemia. Due to the increasing research and study on stem cells, the stem cell characterization kit market is expected to witness significant growth over the forecast period.

The role of stem cell characterization kit is very important because if the stem cells are not characterized properly into required adult cell type, transplanted stem cells may revert back to teratomas and there is a possibility of transplant rejection. This is expected to influence the growth of the stem cell characterization kit market.

More Related Reports By Fact.MR On Healthcare Domain :

Veterinary Endodontics MarketVeterinary Endodontics Market Forecast, Trend Analysis & Competition Tracking Global Review 202Artificial Eyes to 203Artificial Eyes

Hemorrhoids Treatment Device MarketHemorrhoids Treatment Devices Market Forecast, Trend, Analysis & Competition Tracking Global Market Insights 202Artificial Eyes to 203Artificial Eyes

About Fact.MR

Market research and consulting agency with a difference! Thats why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and well be an able research partner.

Contact:US Sales Office :11140 Rockville PikeSuite 400Rockville, MD 20852United StatesTel: +1 (628) 251-1583E-Mail:sales@factmr.com

Corporate Headquarter:Unit No: AU-01-H Gold Tower (AU),Plot No: JLT-PH1-I3A,Jumeirah Lakes Towers,Dubai, United Arab Emirates

Visit Our Website:https://www.factmr.com

Read more from the original source:
Chronic Diseases Is Expected To Have Positive Impact On Stem Cell Characterization Kits Market Demand Bloomingprairieonline - Bloomingprairieonline

Posted in California Stem Cells | Comments Off on Chronic Diseases Is Expected To Have Positive Impact On Stem Cell Characterization Kits Market Demand Bloomingprairieonline – Bloomingprairieonline